SpaceX (SPCX) Stock Prediction: $203 Bull, $103 Bear

SpaceX is not trading like a growth IPO that the market is still discovering; it is trading like a supply schedule. Space Exploration Technologies Corp. (Nasdaq: SPCX) closed Friday 25 September 2026 at $148.68, according to Nasdaq historical data. That is 10.1% above the $135.00 offer price but 7.6% below its $160.95 first-day close on 12 June and 26.3% below its $201.80 closing high of 16 June. The business itself is accelerating: second-quarter revenue rose 92% year on year to $7.81 billion and adjusted EBITDA rose 191% to $3.54 billion, per SpaceX’s Q2 2026 earnings release of 4 August. What holds the share price down is the lock-up calendar in the final 424(b)(4) prospectus. Our scenarios for 31 March 2027: a $203 bull case, a $158 base case and a $103 bear case, each built from a revenue run-rate multiplied by a multiple the stock has already traded at.

Most coverage treats 8 December as the lock-up date to watch. The prospectus shows it is not the biggest. Between now and 8 December, up to 2.75 billion more Class A shares become transferable in four tranches: 328.4 million on 9 October, 328.4 million on 24 October, 1.3 billion on the second full trading day after the third-quarter results, and 797.6 million on 8 December. At Friday’s close that is about $409.5 billion of stock. The Nasdaq-100 rebalance that more than doubled SpaceX’s index weight on 21 September added an estimated $15.5 billion to $22 billion of forced passive buying, by FinanceFeeds’ earlier estimate. That puts the unlocked supply at roughly 19 to 26 times the index bid. The largest single release, 1.3 billion shares, comes after the Q3 earnings print, not in December. That makes the Q3 print the most important SPCX event of the next six months.

What is actually happening to SPCX stock, and why the lock-up calendar matters

An IPO lock-up is a contract in which pre-IPO holders agree not to sell for a set period, and SpaceX’s is unusually detailed. According to the prospectus, everything outside Elon Musk and a group of long-term holders sits in a “180-day lock-up period” that expires on 8 December 2026, with automatic early releases along the way. Those releases are 20% of the pool after the first earnings release, 7% on each of 20 August, 9 September, 24 September, 9 October and 24 October, 28% after the third-quarter results, and the remainder on day 180. A separate “extended” lock-up covers about 7.8 billion shares, roughly 60% of the post-IPO share count and including all of Musk’s holding. It releases in slices tied to the Q4 2026, Q1 2027 and Q2 2027 results. Musk’s own shares are locked for 366 days, until 12 June 2027.

There was also a conditional accelerator. If SPCX had closed at least 30% above the $135 offer price, meaning $175.50, on five of the ten trading days ending on the first earnings date, another 455.8 million shares would have come free early. The Nasdaq closes show the highest close in that window was $125.33 on 4 August. The accelerator did not trigger. That is why the prospectus’s larger 8 December figure, 797.6 million shares, is the one that applies rather than 328.4 million. FinanceFeeds has covered the 8 December date before. The new point is its size relative to the rest of the schedule.

Think of it as a reservoir with sluice gates: opening a gate means the water can leave, not that it will. The first large gate opened on 6 August with up to 911.5 million shares, the day after SPCX closed at its $108.27 low following the Q2 print. The stock did not collapse. It closed at $146.15 by 12 August, up 35.0% in five sessions, according to Nasdaq closes. The 9 September release of up to 319.0 million shares, which FinanceFeeds tracked on the day, passed with a 3.9% one-day fall from $153.47 to $147.55. So far, holders have sold in measured amounts.

The 1.3 billion shares released after the third-quarter results are different: they arrive alongside new numbers, so any disappointment meets the most supply at once. SpaceX has not yet announced its Q3 date. The Q2 release came 35 days after quarter end, which would put a comparable Q3 release around 4 November. That date is our inference, not a company statement. SpaceX’s chief financial officer framed the long-term case in a pre-IPO interview filed with the SEC as a free writing prospectus on 9 June:

“Well as soon as we can bring back that second stage to the tower and start rapidly reusing it in the next couple of years, I think you’re going to experience a 10x from a cost per kilogram to space from where we’re at with Falcon today.” — Bret Johnsen, Chief Financial Officer at SpaceX

Quick Take: The accelerator did not trigger, so 8 December releases up to 797.6 million shares. The heavier date is the second trading day after Q3 results, with up to 1.3 billion.

How insiders, funds and SpaceX itself are responding

The filings show supply being managed, not dumped. Gwynne Shotwell, SpaceX’s President and COO, filed a Form 144 on 22 September covering 342,170 shares with an aggregate market value of $51.96 million. Her Form 4 shows she exercised options at strike prices of $8.40 to $19.40 and sold exactly 342,170 shares that day at weighted-average prices between $151.15 and $154.72. The sale was made under a Rule 10b5-1 plan adopted on 23 June 2026. After it she still held 2,472,035 shares directly, plus shares held through two family trusts. That is a small, pre-scheduled sale.

Venture holders are behaving differently. Antonio Gracias, a SpaceX director whose Valor Equity Partners vehicles are early backers, reported in a Form 4 dated 11 September that Valor entities made pro-rata in-kind distributions of 42,790,223 Class A shares to their own investors. The distribution followed a 10b5-1 plan adopted on IPO day, 12 June. Valor-linked entities still held 460,624,307 shares afterwards. In-kind distributions matter because they move shares from one patient holder to many limited partners, each deciding separately whether to sell.

Sovereign money sits on the other side. Saudi Arabia’s Public Investment Fund reported 154.1 million SPCX shares in its 30 June Form 13F, which FinanceFeeds covered in detail on 11 September. Four Schedule 13G filings, the form used by passive holders crossing 5%, arrived between 11 and 14 August, according to SpaceX’s EDGAR filing index.

SpaceX has also added shares of its own. It closed the Cursor (Anysphere) acquisition on 14 August and issued 389,289,254 Class A shares plus 1,752,426 shares for vested units, according to its 8-K. That was on a $60.0 billion equity value, implying roughly $154.13 per share, above Friday’s close. Those shares were issued in a private placement and are not yet registered for resale. The company also sold $25 billion of investment-grade notes in June at a 5.855% weighted-average coupon, per the Q2 release, so it is not relying on equity alone for its compute build-out. The CFO commentary in that release described the balance sheet directly:

“We ended the second quarter with $100 billion of cash, cash equivalents, and marketable securities, and $47.5 billion in backlog.” — CFO commentary, SpaceX Q2 2026 earnings release (Bret Johnsen is SpaceX’s Chief Financial Officer)

Quick Take: The executive sells small, the venture fund distributes large blocks, and the sovereign fund holds.

SPCX market impact and valuation: what the numbers say

Start with the valuation. SpaceX reported 7,696,293,669 Class A and 5,485,486,276 Class B shares outstanding at 28 July, per its 10-Q. Adding the 391.0 million Cursor shares gives about 13.57 billion shares. At $148.68 that is a market value of about $2.02 trillion. Net cash at 30 June was $60.6 billion: $100.0 billion of cash and marketable securities less $39.4 billion of debt and finance leases. Enterprise value is therefore about $1.96 trillion. Annualising Q2 revenue of $7.814 billion gives a $31.26 billion run-rate. SPCX trades at 62.6 times run-rate revenue.

The market has already shown where it will price SPCX under stress. At the 5 August close of $108.27 there were 13.18 billion shares, the pre-Cursor count, and the same Q2 run-rate had just been published. That works out to 43.7 times. Both of our multiples come from the stock’s own trading range rather than from peer companies.

Scenario (31 Mar 2027)	Q4 2026 revenue run-rate	EV / run-rate	Arithmetic	Per share
Bull	$44.0bn ($11.0bn a quarter)	62x (today’s)	(62 × 44.0 + 30) ÷ 13.6	$203 (+36%)
Base	$40.0bn ($10.0bn a quarter)	53x (midpoint)	(53 × 40.0 + 30) ÷ 13.6	$158 (+6%)
Bear	$31.3bn (flat on Q2)	44x (5 Aug low)	(44 × 31.26 + 30) ÷ 13.6	$103 (−31%)

Three checkable assumptions sit under the table. First, net cash falls to about $30 billion by year end. Six-month operating cash flow was $3.47 billion against $28.48 billion of capex, so free cash flow was roughly minus $25 billion in the first half, and we assume two more quarters at about minus $15 billion each. Second, the share count rises to 13.6 billion as option exercises like Shotwell’s continue. Third, the base case needs about 13% quarter-on-quarter revenue growth into Q4. That is well below Q2’s 66% sequential jump, which was driven by $1.6 billion of new AI infrastructure revenue from $14.1 billion of contracted compute sales. The bull case needs about 19% a quarter. The bear case assumes Q2 was a lumpy peak and the 5 August multiple returns.

The segments explain the wide multiple range. Connectivity is steady: $4.29 billion of revenue and $1.66 billion of operating income in Q2, up 66% and 79%. Space lost $542 million at the operating line as launches fell to 38 from 46 a year earlier and mass to orbit fell to 485 tonnes from 652, while Starship R&D rose. AI booked $2.56 billion of revenue on $15.83 billion of capex in one quarter. The equity story depends on that capex earning a return. For a listed comparison, see our Rocket Lab (RKLB) bull and bear cases and the SpaceX versus Honeywell Aerospace comparison.

The two operating offsets named in most bull cases can be measured. Starlink ARPU fell 22.4% year on year to $66. Each $1 of monthly ARPU on 12.0 million subscribers is worth about $144 million of annual revenue, so recovering to $85 would add roughly $2.7 billion a year. That is small against a $2 trillion market value. Starship cadence is harder to value. SpaceX flew Flight 12 in May and Flight 13 in July, the latter deploying 20 production V3 satellites. The company says the vehicle will cut cost to orbit by “99% or more” relative to the historical average. That is a claim about the future, not a reported figure.

Prediction-market pricing sits close to our base case. On 28 September Polymarket’s “SPCX above ___ end of October” market priced 78% for a close above $130, 63% above $140, 45.5% above $150, 29.5% above $160, 13% above $180 and 11% above $200. The implied median is near $148. Liquidity was only about $10,326 and the ladder is not monotonic ($190 at 10%, $200 at 11%), so treat it as sentiment, not a target.

Regulatory landscape: who controls SPCX, and the rules on insider sales

Two regulatory features shape SPCX’s supply more than any FAA or FCC headline. The first is governance. At the offer price, Musk held about 82.4% of the combined voting power, mostly through 10-vote Class B shares, per the prospectus cover. That makes SpaceX a Nasdaq “controlled company” exempt from some board-independence requirements. Outside shareholders cannot vote to change capital allocation, including the $15.8 billion-a-quarter AI build-out and the separately discussed idea of a Tesla combination, which FinanceFeeds priced in Tesla SpaceX merger math.

The second is the SEC’s 2022 overhaul of Rule 10b5-1. Under the amendments, directors and officers must wait the later of 90 days after adopting a plan, or two business days after the company reports results for the quarter in which the plan was adopted, before trading. Shotwell adopted her plan on 23 June. Ninety days later was 21 September, and her first reported sale was 22 September. That makes insider selling easier to forecast: plans adopted in late June become eligible to trade from late September. When the SEC adopted the amendments, it said:

“Over the past two decades, though, we’ve heard from courts, commenters, and members of Congress that insiders have sought to benefit from the rule’s liability protections while trading securities opportunistically on the basis of material nonpublic information. I believe today’s amendments will help fill those potential gaps.” — Gary Gensler, then Chair of the U.S. Securities and Exchange Commission, 14 December 2022

On the operating side, the Q2 release says the FCC approved the transfer of EchoStar’s licences for 65 MHz of U.S. spectrum and certain global Mobile Satellite Service rights. SpaceX also reported more than $6 billion of multi-year U.S. government Starshield awards, mainly from two Space Force contracts. Neither changes the unlock arithmetic.

Quick Take: Musk’s voting control rules out an activist path to value, and the 10b5-1 cooling-off rule makes insider selling predictable. Both limit how much of the unlock the market can wave away.

What happens next: three SPCX predictions

1. The Q3 print sets the path to December. Our base case assumes about $8.9 billion of Q3 revenue, on the way to $10.0 billion in Q4. If SpaceX reports near or above that and AI Adjusted EBITDA stays positive after Q2’s $1.15 billion, the 1.3 billion-share release that follows should be absorbed the way August’s 911.5 million was. If revenue stalls near Q2’s $7.81 billion, both the new supply and a weaker growth rate hit the stock on the same day. That is the fastest route to the bear case.

2. 8 December will be less important than the calendar suggests. By then, up to about 4.53 billion shares, including the 638.9 million sold in the IPO, will already be free to trade. The 797.6 million shares in the final tranche are 17.6% of that pool and 5.9% of all shares outstanding. We expect 8 December to be a volume event, not a price event.

3. The passive bid has already been spent. The 18 September rebalance session printed 335.7 million shares, the heaviest volume since the 522.1 million on IPO day, and SPCX still closed down 1.4%. It has fallen 3.9% from the 22 September close. We have seen no announced December weight change, so index demand is unlikely to return before the next reconstitution.

Our base case is $158 by 31 March 2027. The main thing to watch is the Q3 revenue figure: roughly $8.9 billion or more supports the base case, and a flat print near $7.8 billion points toward $103.

Frequently asked questions

What is the SpaceX (SPCX) stock prediction for 2027?

FinanceFeeds’ scenarios for 31 March 2027 are $203 bull, $158 base and $103 bear. Each applies an enterprise-value multiple the stock has already traded at (62x today, 43.7x at the 5 August low) to a Q4 2026 revenue run-rate of $44 billion, $40 billion or $31.3 billion. We then add about $30 billion of net cash and divide by 13.6 billion shares.

When does the SpaceX lock-up expire?

The 180-day lock-up for most pre-IPO holders ends on 8 December 2026, when up to 797.6 million Class A shares become transferable, per the 424(b)(4) prospectus. Musk’s shares are locked until 12 June 2027.

How many SpaceX shares unlock after the Q3 2026 results?

Up to 1.3 billion Class A shares, 28% of the 180-day locked pool, become transferable on the second full Nasdaq trading day after SpaceX publishes its third-quarter results. It is the largest single release before year end. SpaceX has not yet announced the Q3 reporting date.

Why is SPCX trading below its first-day close?

SPCX closed at $148.68 on 25 September, 7.6% below its $160.95 first close. At that price the stock trades at about 62.6 times annualised Q2 revenue. Up to 2.58 billion shares, including the IPO float, are already free to trade and another 2.75 billion are scheduled by 8 December.

Did the SpaceX lock-up early-release accelerator trigger?

No. It required closes at least 30% above the $135 offer price, or $175.50, on five of the ten trading days ending 4 August. The highest close in that window was $125.33. As a result, the additional 455.8 million shares were not released early and roll into the 8 December tranche.

This article is for information only and is not investment advice. Figures are from the sources linked and were checked on 28 September 2026.